Cedivac-FMD can be used according to a marker vaccine principle

G. Chénard, P.J. Selman, A. Dekker

    Research output: Contribution to journalArticleAcademicpeer-review

    5 Citations (Scopus)


    In this study, we investigated whether Cedivac-FMD, an emergency vaccine against foot-and-mouth disease (FMD), is suitable for use conjointly with a screening program intended to confirm freedom from disease in vaccinated herds based on evidence of virus replication in vaccinates. Different sets of sera were tested using the Ceditest® FMDV-NS ELISA for the detection of antibodies against non-structural proteins (NSPs) of FMD virus. During a vaccine safety study, serum samples were collected from 10 calves, 10 lambs and 10 piglets following administration of a double dose and a repeat dose of high payload trivalent Cedivac-FMD vaccine. All serum samples collected both 2 weeks following the administration of a double dose as well as those collected 2 weeks after the single dose booster (given 2 weeks after the double dose) were negative in the Ceditest® FMDV-NS ELISA. In a series of vaccine potency experiments, serum samples were collected from 70 vaccinated cattle prior to and following exposure to infectious, homologous FMD virus. When testing cattle sera collected 4 weeks after vaccination with a regular dose of monovalent >6 PD50 vaccines, 1 of 70 animals tested positive in the NSP antibody ELISA. After infection with FMD virus, antibodies to NSP were detected in 59 of 70 vaccinated cattle and 27 of 28 non-vaccinated control animals within 7 days. Cedivac-FMD vaccines do not induce NSP antibodies in cattle, pigs or sheep following administration of a double dose or a repeat dose. FMD-exposed animals can be detected in a vaccinated group within 7¿14 days. Because Cedivac-FMD does not induce NSP antibodies, the principle of `marker vaccine¿ applies.
    Original languageEnglish
    Pages (from-to)65-71
    JournalVeterinary Microbiology
    Issue number1-2
    Publication statusPublished - 2008


    • mouth-disease virus
    • nonstructural proteins
    • transmission
    • antibodies
    • infection
    • elisa

    Fingerprint Dive into the research topics of 'Cedivac-FMD can be used according to a marker vaccine principle'. Together they form a unique fingerprint.

    Cite this